MD Anderson researchers discovered that a combination of immunotherapy and targeted therapies that block normal DNA damage repair, such as PARP inhibitors, achieved dramatic tumor reduction in mouse models of small cell lung cancer.
from EurekAlert! - Breaking News http://bit.ly/2GyXej0
via IFTTT
Monday, February 18, 2019
Small cell lung cancer may respond to combination of immunotherapy and DNA damage repair inhibitors
About Admin -
Author Description here.. Nulla sagittis convallis. Curabitur consequat. Quisque metus enim, venenatis fermentum, mollis in, porta et, nibh. Duis vulputate elit in elit. Mauris dictum libero id justo.